Replies to post #36066 on OncoSec Medical Inc (ONCSQ)

[hschlauch]

The fact that the AA trial is selecting refractory patients rather than just predicted nonresponders based on a biomarker, suggests to me that enrollment will be much quicker than the current combo trial.